Related references
Note: Only part of the references are listed.A Chemical Biology Approach to Developing STAT Inhibitors: Molecular Strategies for Accelerating Clinical Translation
Erik A. Nelson et al.
Oncotarget (2015)
The Synthetic α-Bromo-2′,3,4,4′-Tetramethoxychalcone (α-Br-TMC) Inhibits the JAK/STAT Signaling Pathway
Sophia Pinz et al.
PLOS ONE (2014)
Sophoraflavanone G induces apoptosis of human cancer cells by targeting upstream signals of STATs
Byung-Hak Kim et al.
BIOCHEMICAL PHARMACOLOGY (2013)
JAK of all trades: JAK2-STAT5 as novel therapeutic targets in BCR-ABL1+ chronic myeloid leukemia
Wolfgang Warsch et al.
BLOOD (2013)
Molecular Pathways: JAK/STAT Pathway: Mutations, Inhibitors, and Resistance
Alfonso Quintas-Cardama et al.
CLINICAL CANCER RESEARCH (2013)
A new player in Pol II pausing
Nicholas J. Fuda et al.
EMBO JOURNAL (2013)
A novel STAT inhibitor, OPB-31121, has a significant antitumor effect on leukemia with STAT-addictive oncokinases
F. Hayakawa et al.
BLOOD CANCER JOURNAL (2013)
Discovery and characterization of LY2784544, a small-molecule tyrosine kinase inhibitor of JAK2V617F
L. Ma et al.
BLOOD CANCER JOURNAL (2013)
Immediate-early gene activation by the MAPK pathways: what do and don't we know?
Amanda O'Donnell et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2012)
Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed
Berkley E. Gryder et al.
FUTURE MEDICINAL CHEMISTRY (2012)
Critical Role of STAT5 Transcription Factor Tetramerization for Cytokine Responses and Normal Immune Function
Jian-Xin Lin et al.
IMMUNITY (2012)
Discovery of Potent and Selective Pyrazolopyrimidine Janus Kinase 2 Inhibitors
Emily J. Hanan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
SUMO-Specific Protease 1 Is Critical for Early Lymphoid Development through Regulation of STAT5 Activation
Thang Van Nguyen et al.
MOLECULAR CELL (2012)
Promoter-proximal pausing of RNA polymerase II: emerging roles in metazoans
Karen Adelman et al.
NATURE REVIEWS GENETICS (2012)
Efficacious Intermittent Dosing of a Novel JAK2 Inhibitor in Mouse Models of Polycythemia Vera
Manfred Kraus et al.
PLOS ONE (2012)
Defining the Status of RNA Polymerase at Promoters
Leighton J. Core et al.
CELL REPORTS (2012)
Regulation of the Keap1/Nrf2 system by chemopreventive sulforaphane: implications of posttranslational modifications
Young-Sam Keum
NUTRITION AND PHYSICAL ACTIVITY IN AGING, OBESITY, AND CANCER (2011)
The STAT5 inhibitor pimozide decreases survival of chronic myelogenous leukemia cells resistant to kinase inhibitors
Erik A. Nelson et al.
BLOOD (2011)
JAK2 inhibitors: What's the true therapeutic potential?
Fabio P. S. Santos et al.
BLOOD REVIEWS (2011)
Discovery of 5 Chloro-N2-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]-N4-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine (AZD1480) as a Novel Inhibitor of the Jak/Stat Pathway
Stephanos Ioannidis et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Epigenetic repression of the Igk locus by STAT5-mediated recruitment of the histone methyltransferase Ezh2
Malay Mandal et al.
NATURE IMMUNOLOGY (2011)
Two Naturally Occurring Terpenes, Dehydrocostuslactone and Costunolide, Decrease Intracellular GSH Content and Inhibit STAT3 Activation
Elena Butturini et al.
PLOS ONE (2011)
AZ960, a Novel Jak2 Inhibitor, Induces Growth Arrest and Apoptosis in Adult T-Cell Leukemia Cells
Jing Yang et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Acetylation modulates prolactin receptor dimerization
Li Ma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Electrophilic tuning of the chemoprotective natural product sulforaphane
Young-Hoon Ahn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
S-Glutathionylation Impairs Signal Transducer and Activator of Transcription 3 Activation and Signaling
Yi Xie et al.
ENDOCRINOLOGY (2009)
The LIM-homeodomain transcription factor LMX1B regulates expression of NF-kappa B target genes
Anne Rascle et al.
EXPERIMENTAL CELL RESEARCH (2009)
Dietary Sulforaphane, a Histone Deacetylase Inhibitor for Cancer Prevention
Emily Ho et al.
JOURNAL OF NUTRITION (2009)
Temporal Changes in Gene Expression Induced by Sulforaphane in Human Prostate Cancer Cells
Suvarna Bhamre et al.
PROSTATE (2009)
A high-throughput assay for signal transducer and activator of transcription 5b based on fluorescence polarization
Judith Mueller et al.
ANALYTICAL BIOCHEMISTRY (2008)
Multi-targeted prevention of cancer by sulforaphane
John D. Clarke et al.
CANCER LETTERS (2008)
Discovery of chromone-based inhibitors of the transcription factor STAT5
Judith Mueller et al.
CHEMBIOCHEM (2008)
In vivo identification of novel STAT5 target genes
Beth Basham et al.
NUCLEIC ACIDS RESEARCH (2008)
Dietary histone deacetylase inhibitors: From cells to mice to man
Roderick H. Dashwood et al.
SEMINARS IN CANCER BIOLOGY (2007)
Molecular basis for chemoprevention by sulforaphane: a comprehensive review
N. Juge et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
Chalcone inhibits the activation of NF-κB and STAT3 in endothelial cells via endogenous electrophile
Yen-Chin Liu et al.
LIFE SCIENCES (2007)
Gene expression profiles induced by cancer chemopreventive isothiocyanate sulforaphane in the liver of C57BL/6J mice and C57BL/6J/Nrf2 (-/-) mice
Rong Hu et al.
CANCER LETTERS (2006)
Mechanism of action of sulforaphane: Inhibition of p38 mitogen-activated protein kinase isoforms contributing to the induction of antioxidant response element-mediated heme oxygenase-1 in human hepatoma HepG2 cells
Young-Sam Keum et al.
CANCER RESEARCH (2006)
Sulforaphane inhibits histone deacetylase activity in BPH-1, LnCaP and PC-3 prostate epithelial cells
MC Myzak et al.
CARCINOGENESIS (2006)
JAW/STAT signal transduction: Regulators and implication in hematological malignancies
L Valentino et al.
BIOCHEMICAL PHARMACOLOGY (2006)
ERK and JNK signaling pathways are involved in the regulation of activator protein 1 and cell death elicited by three isothiocyanates in human prostate cancer PC-3 cells
CJ Xu et al.
CARCINOGENESIS (2006)
Identification of sensor cysteines in human Keap1 modified by the cancer chemopreventive agent sulforaphane
F Hong et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2005)
SOCS-3 is frequently methylated in head and neck squamous cell carcinoma and its precursor lesions and causes growth inhibition
A Weber et al.
ONCOGENE (2005)
Role of PI3K/Akt and MEK/ERK signaling pathways in sulforaphane- and erucin-induced phase II enzymes and MRP2 transcription, G2/M arrest and cell death in Caco-2 cells
J Jakubíková et al.
BIOCHEMICAL PHARMACOLOGY (2005)
STAT3- and DNA methyltransferase 1-mediated epigenetic silencing of SHP-1 tyrosine phosphatase tumor suppressor gene in malignant T lymphocytes
Q Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Involvement of c-Jun N-terminal kinase in G(2)/M arrest and caspase-mediated apoptosis induced by sulforaphane in DU145 prostate cancer cells
SD Cho et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2005)
Modulation of AP-1 by natural chemopreventive compounds in human colon HT-29 cancer cell line
WS Jeong et al.
PHARMACEUTICAL RESEARCH (2004)
Inhibitors of JAKs/STATs and the kinases: a possible new cluster of drugs
C Luo et al.
DRUG DISCOVERY TODAY (2004)
A novel mechanism of chemoprotection by sulforaphane: Inhibition of histone deacetylase
MC Myzak et al.
CANCER RESEARCH (2004)
SOCS1 and SHP1 hypermethylation in multiple myeloma:: implications for epigenetic activation of the Jak/STAT pathway
CS Chim et al.
BLOOD (2004)
Elongation by RNA polymerase II: the short and long of it
RJ Sim et al.
GENES & DEVELOPMENT (2004)
SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer
B He et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
NCoA-1/SRC-1 is an essential coactivator of STAT5 that binds to the FDL motif in the α-helical region of the STAT5 transactivation domain
CM Litterst et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Cancer chemoprevention with dietary phytochemicals
YJ Surh
NATURE REVIEWS CANCER (2003)
Deacetylase activity is required for recruitment of the basal transcription machinery and transactivation by STAT5
A Rascle et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Chromatin acetylation and remodeling at the Cis promoter during STAT5-induced transcription
A Rascle et al.
NUCLEIC ACIDS RESEARCH (2003)
NF-κB elements contribute to junB inducibility by lipopolysaccharide in the murine macrophage cell line RAW264.7
MR Frazier-Jessen et al.
FEBS LETTERS (2002)
Signal transduction events elicited by cancer prevention compounds
ANT Kong et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2001)
Molecular mechanism of rapid cellular accumulation of anticarcinogenic isothiocyanates
YS Zhang
CARCINOGENESIS (2001)
Modulation of STAT signaling by STAT-interacting proteins
K Shuai
ONCOGENE (2000)
Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2
J Schwaller et al.
MOLECULAR CELL (2000)
Share Paper
